Anavex Life Sciences (AVXL) Shareholder's Equity Growth (1y) (2011 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Anavex Life Sciences | 266.20 Mn | 134.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 14.16% |
| Sep 30, 2025 | -21.12% |
| Jun 30, 2025 | -29.91% |
| Mar 31, 2025 | -26.08% |
| Dec 31, 2024 | -18.19% |
| Sep 30, 2024 | -15.22% |
| Jun 30, 2024 | -11.57% |
| Mar 31, 2024 | -7.03% |
| Dec 31, 2023 | 0.33% |
| Sep 30, 2023 | -0.45% |
| Jun 30, 2023 | -2.64% |
| Mar 31, 2023 | -4.63% |
| Dec 31, 2022 | -7.68% |
| Sep 30, 2022 | -5.52% |
| Jun 30, 2022 | -4.08% |
| Mar 31, 2022 | 100.77% |
| Dec 31, 2021 | 216.12% |
| Sep 30, 2021 | 453.72% |
| Jun 30, 2021 | 536.71% |
| Mar 31, 2021 | 205.79% |
| Dec 31, 2020 | 78.35% |
| Sep 30, 2020 | 34.24% |
| Jun 30, 2020 | 16.48% |
| Mar 31, 2020 | 44.27% |
| Dec 31, 2019 | 33.38% |
| Sep 30, 2019 | -9.10% |
| Jun 30, 2019 | -10.16% |
| Mar 31, 2019 | -23.55% |
| Dec 31, 2018 | -23.81% |
| Sep 30, 2018 | -13.76% |
| Jun 30, 2018 | 0.57% |
| Sep 30, 2017 | 310.32% |
| Sep 30, 2016 | -50.75% |
| Sep 30, 2015 | 6,549.68% |
| Jun 30, 2015 | -11.33% |
| Mar 31, 2015 | -44.07% |
| Dec 31, 2014 | 128.33% |
| Sep 30, 2014 | 107.82% |
| Jun 30, 2014 | 308.50% |
| Mar 31, 2014 | 344.79% |
| Dec 31, 2013 | 49.82% |
| Sep 30, 2013 | 14.33% |
| Jun 30, 2013 | -61.68% |
| Mar 31, 2013 | -17.29% |
| Sep 30, 2012 | -151.68% |
| Sep 30, 2011 | 61.41% |